Prosecution Insights
Last updated: October 23, 2026
Application No. 19/101,644

HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR

Non-Final OA §102§Other
Filed
Feb 06, 2025
Priority
Aug 10, 2022 — nonprovisional of PCTBR2022050313
Examiner
YOUNG, MICAH PAUL
Art Unit
1618
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
L'Oréal
OA Round
1 (Non-Final)
55%
Grant Probability
Moderate
1-2
OA Rounds
1y 11m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allowance Rate
543 granted / 984 resolved
-4.8% vs TC avg
Strong +30% interview lift
Without
With
+30.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
47 currently pending
Career history
1049
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
56.4%
+16.4% vs TC avg
§102
17.6%
-22.4% vs TC avg
§112
9.6%
-30.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 984 resolved cases

Office Action

§102 §Other
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 2/6/25 was filed in a timely manner. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-14, 17, 18, 21 and 22 is/are rejected under 35 U.S.C. 102a1,2 as being anticipated by Nakano et al (US 2019/0201305 A1 hereafter Nakano). Nakano discloses a hair care cosmetic composition comprising at least one organic acid, a non-aqueous solvent comprising a hydroxyl group, an amino acid, a fatty compound including vegetal waxes, water and at least one surfactant that can be cationic, anionic or nonionic [abstract, 003-004, 0267, claims]. The organic acid is alpha hydroxy acid [0068]. The organic acid includes citric or tartaric acid [0091]. The organic acid is present in a concentration of 1% [Table 1b]. The non-aqueous solvent, including propylene glycol and glycerin, present up to 25% [0024]. The fatty compound is a vegetal fat such as balsam resin, where the fatty vegetal source is present at 1% [0262, Table 2b]. The amino acid is arginine or glycine where the arginine is present at 1% [0156, Table 1c]. The one fatty compound can be a vegetal oil like coconut oil and beeswax [0030, 0113]. The one surfactant can be a nonionic surfactant like myristyl or stearyl alcohol, present from 0.5-5% [0071-0073]. The formulation comprises perfumes and fragrances [0261-0262]. The reference discloses a method of treating hair by applying the formulation to the hair [claim 14]. These disclosures render the claims anticipated. Claim(s) 1-9, 12, 13, 15-17, 21 and 22 is/are rejected under 35 U.S.C. 102a1,2 as being anticipated by Reith et al (US 2015/0252302 A1 hereafter Reith). Reith discloses a hair cleaning composition (abstract). The formulation comprises an organic acid, such as alpha or beta hydroxy acids or glycolic, lactic acid present about 1-10% [0117, 0185]. The non-aqueous solvent includes ethanol, propylene glycol where the ethanol is present from 0.1-5% [0100, 0165]. The formulation comprises amino acids such as arginine and glycine [0237]. The formulation comprises a fatty compound such as a vegetal oil like coconut or soybean oil or candelilla or carnuaba wax [0110, 0295]. The formulation comprises anionic, cationic or non-ionic surfactants [0141]. The cationic surfactants can be quaternary ammonium dimethyl benzyl ammonium salts present about 0.1-2% [0165]. The nonionic surfactant can be fatty alcohols like alkoxylated alcohols present about 5-10% [0122]. The formulation comprises fragrances and water [0228]. The formulation is applied in a method of cleaning the hair by applying the formulation to the hair [claims]. These disclosures render the claims anticipated. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICAH PAUL YOUNG whose telephone number is (571)272-0608. The examiner can normally be reached Monday through Friday, 9:00 am to 5:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Hartley can be reached at 5712720616. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICAH PAUL YOUNG/Primary Examiner, Art Unit 1618
Read full office action

Prosecution Timeline

Feb 06, 2025
Application Filed
Oct 02, 2026
Non-Final Rejection mailed — §102, §Other (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758655
METHODS AND SYSTEMS FOR NONINVASIVE CONTROL OF BRAIN CELLS AND RELATED VECTORS AND COMPOSITIONS
4y 3m to grant Granted Oct 13, 2026
Patent 12746598
BIMETALLIC FLUORESCENT NANOCOMPOSITES FOR CANCER THERANOSTICS
4y 0m to grant Granted Sep 29, 2026
Patent 12734254
PROBE DIRECTED TO ENZYME ALDH1A3 AND USE THEREOF IN THE DIAGNOSIS OF GLIOBLASTOMA
2y 11m to grant Granted Sep 15, 2026
Patent 12714677
DUAL CHAMBER SYRINGE FOR ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL
1y 6m to grant Granted Aug 25, 2026
Patent 12708605
METHOD OF ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL WITH A DUAL CHAMBER SYRINGE
1y 5m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
55%
Grant Probability
85%
With Interview (+30.0%)
3y 7m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 984 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month